Values First Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
40,301
+6,602
+20% +$356K 1.3% 15
2026
Q1
$1.76M Sell
33,699
-222
-0.7% -$13.3K 0.92% 36
2025
Q4
$1.99M Sell
33,921
-1,613
-5% -$98K 1.04% 25
2025
Q3
$1.98M Sell
35,534
-554
-2% -$29.7K 1.06% 26
2025
Q2
$1.86M Buy
36,088
+8,638
+31% +$434K 1.01% 22
2025
Q1
$1.61M Buy
27,450
+140
+0.5% +$9.49K 0.94% 30
2024
Q4
$1.97M Sell
27,310
-1,266
-4% -$93K 1.08% 21
2024
Q3
$2.28M Sell
28,576
-322
-1% -$24.2K 1.24% 18
2024
Q2
$2.07M Buy
28,898
+6,779
+31% +$499K 1.24% 20
2024
Q1
$1.56M Sell
22,119
-203
-0.9% -$14.5K 0.91% 34
2023
Q4
$1.72M Buy
22,322
+101
+0.5% +$6.65K 1.04% 30
2023
Q3
$1.51M Sell
22,221
-249
-1% -$19.7K 0.98% 34
2023
Q2
$1.83M Buy
22,470
+4,775
+27% +$384K 1.11% 25
2023
Q1
$1.31M Buy
17,695
+223
+1% +$17.2K 0.84% 33
2022
Q4
$1.45M Sell
17,472
-480
-3% -$38.1K 1.01% 31
2022
Q3
$1.27M Buy
17,952
+404
+2% +$34.9K 0.92% 34
2022
Q2
$1.52M Sell
17,548
-132
-0.7% -$12.4K 1.08% 32
2022
Q1
$1.91M Buy
17,680
+192
+1% +$19.8K 1.21% 22
2021
Q4
$2.26M Sell
17,488
-2,780
-14% -$341K 1.34% 17
2021
Q3
$2.46M Buy
20,268
+292
+1% +$35.5K 1.59% 14
2021
Q2
$2.25M Sell
19,976
-2,828
-12% -$298K 1.53% 16
2021
Q1
$2.18M Buy
22,804
+436
+2% +$39.8K 1.61% 10
2020
Q4
$1.77M Buy
22,368
+12
+0.1% +$869 1.41% 17
2020
Q3
$1.38M Buy
22,356
+260
+1% +$16.9K 1.27% 25
2020
Q2
$1.46M Sell
22,096
-6,352
-22% -$380K 1.44% 16
2020
Q1
$1.35M Buy
28,448
+1,376
+5% +$68.8K 1.62% 14
2019
Q4
$1.49M Buy
+27,072
New +$1.42M 1.43% 17

Other funds holding TECH

Values First Advisors's TECH Position: Q2 2026 in Review

Values First Advisors increased its Bio-Techne (TECH) stake by 20% in Q2 2026, buying an estimated $356K and bringing the position to 40,301 shares worth $2.85M. The position accounts for 1.3% of the portfolio, ranked #15.

Values First Advisors first reported a position in TECH in Q4 2019 and has held it in 27 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Values First Advisors held 40,301 shares of Bio-Techne worth $2.85M as of Q2 2026.
  • Values First Advisors bought 6,602 Bio-Techne shares in Q2 2026, an estimated $356K.
  • Bio-Techne made up 1.3% of Values First Advisors's portfolio in Q2 2026, its #15 holding.
  • Values First Advisors first reported a position in Bio-Techne in Q4 2019 and has held it in 27 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Values First Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.